Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Inovio Stock Is Still a Strong Coronavirus-Related Bet to Make

By Louis Navellier and the InvestorPlace Research Staff
Inovio is speeding toward a vaccine for the coronavirus and has plans to make 1 million doses by the end of the year to boost INO stock.

Should You Buy Toyota Stock Despite the Coronavirus’ Impact?

By InvestorPlace Research Staff
Toyota stock has weathered the coronavirus storm with surprising resilience. Can it keep it up as it focuses on long-term growth?

The 15 Best Tech Stocks to Buy on the Dip in June

By Luke Lango, InvestorPlace Senior Investment Analyst
Wall Street went "all-in" with tech stocks as the physical economy shutdown, but with the economy recovering, they're starting to see a dip.

DocuSign Stock Is Perfectly Positioned to Power Past the Pandemic

By InvestorPlace Research Staff
Whether there's a spike in the coronavirus or not, DocuSign stock can still continue to push higher due its superior and convenient product.

3 Auto Stocks to Trade Into 2021 for a High Performance Portfolio

By Nicolas Chahine, InvestorPlace Contributor
Experts got too happy about the macroeconomic recovery. Auto stocks will remain under pressure for a while so caution is warranted.

After a Long Ride Down, Things Are Looking up for Nokia Stock

By Larry Ramer, InvestorPlace Contributor
Nokia stock looks well-positioned for a good run, as the company is poised to benefit from Huawei's problems and a new CEO.

Microsoft Stock Will Dominate With Amplified Cloud Computing Strength

By Divya Premkumar, InvestorPlace Contributor
Tech giants like Microsoft are set to emerge from the pandemic stronger than ever. With a $1.5 trillion dollar valuation and increased demand for cloud computing, the race to $2 trillion lies ahead.

Despite Earnings Miss, Stitch Fix Will Return to Its Winning Ways

By Louis Navellier and the InvestorPlace Research Staff
Stitch Fix didn't have a great quarterly earnings report, but there are two strong catalysts that will help boost SFIX stock going forward.

Here’s Where to Buy Alibaba Shares on the Dip

By Bret Kenwell, InvestorPlace Contributor
Whether coronavirus is growing or contracting, Alibaba's business continues to climb. That's why I like Alibaba stock on a dip.

7 of the Best Bank Stocks to Cash In On

By Louis Navellier and the InvestorPlace Research Staff
I'm not usually a fan of big banks, but these seven bank stocks have massive growth potential thanks to their strong regional markets.

3 Reasons CrowdStrike Stock Can Breakout to New Highs

By InvestorPlace Research Staff
CrowdStrike stock continues to hover near its highs as the coronavirus fuels growth. CRWD stock remains a favorable among growth investors.

Electronic Arts Can Bank on a Potentially Huge NFL Season

By InvestorPlace Research Staff
During the depths of the coronavirus pandemic, EA stock jumped on the home-entertainment angle. But as the resilient popularity of the NFL proves, Electronic Arts’ exclusive license with the sports league will pay off handsomely.

The Trend Is Still Your Friend With Micron

By Louis Navellier and the InvestorPlace Research Staff
Check the data and you'll surely agree that MU stock isn't just a tech-sector runner but also a superior value.

Coronavirus Research Is the Key for AIM ImmunoTech Stock

By Louis Navellier and the InvestorPlace Research Staff
One big breakthrough moment in coronavirus research could bring wealth to AIM ImmunoTech. It could also bring big gains to AIM stock.

3 Reasons to Buy Lululemon Stock on Weakness

By Luke Lango, InvestorPlace Senior Investment Analyst
Lululemon's earnings showed that the company is as good as it gets in retail, and that the big rally in LULU stock isn't over yet.

Eli Lilly Is a Big Pharma Play With Big Potential

By Louis Navellier and the InvestorPlace Research Staff
Eli Lilly is known for its Big Pharma dominance, but it's also leading cutting-edge coronavirus research. That makes LLY stock a buy here.

People Will Keep on Spending and Visa Will Benefit

By Louis Navellier and the InvestorPlace Research Staff
Spending patterns won't be exactly the same, but V stockholders will reap the benefits as the company easily adapts.

Expect Even More Upside for Advanced Micro Devices

By Todd Shriber, InvestorPlace Contributor
Advanced Micro Devices is one of the chip space's leaders this year. You can expect that reign to continue for AMD stock.

Buy Uber Stock on Weakness as Trends Point to Big Boost for Ride Sharing

By Larry Ramer, InvestorPlace Contributor
Continued reopenings, along with decreased use of mass transit and the rebounding of flying, will prove to be a winning formula for Uber stock.
Load More Articles